Triple

T1151180
Position Surface form Disambiguated ID Type / Status
Subject International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E23680 entity
Predicate formerName P65 FINISHED
Object International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use E23680 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use | Statement: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, formerName, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, formerName, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • C. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • D. ICH E6 Good Clinical Practice
    ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
  • E. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493f0d32c8190ac74bad3c87f2641 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc744e7c81908f8612f2aad28600 completed March 1, 2026, 10:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac667a61248190b71033daadef58e3 completed March 7, 2026, 5:55 p.m.
Created at: March 1, 2026, 7:44 p.m.